Mescaline of the genus "Echinopsis" are technically controlled substances under the Controlled Substances Act, they are commonly sold publicly as ornamental plants. In the United Kingdom, mescaline in purified powder form is a Class A drug. However, dried cactus can be bought and sold legally. Mescaline is considered a schedule 9 substance in Australia under the Poisons Standard (October 2015). A schedule 9 substance is classified as "Substances with a high potential for causing harm at low exposure and which require special precautions during manufacture, handling or use. These poisons should be available only to specialised or authorised users who have
NBOMe-mescaline NBOMe-mescaline NBOMe-mescaline or mescaline-NBOMe is a synthetic substituted phenethylamine. It is a partial agonist of serotonin receptors with a 5-HT pKi originally reported as 7.3 (i.e. Ki of approximately 50nM), though more modern techniques assayed it as 140nM at 5-HT and 640nM at 5-HT, making it one of the least potent compounds among the n-benzyl phenethylamines. NBOMe-mescaline and NBOMe-escaline were first reported in 1999 resulting from research performed at Free University of Berlin concerning their activity as partial agonists at rat vascular 5-HT2A receptors. NBOMe-mescaline was first reported in September 2008 to have been self administered by humans as a